Noninvasive Diagnosis of Liver Fibrosis and Cirrhosis in Chronic Hepatitis C Patients

Journal of Clinical Laboratory Analysis

Volumn 27, Issue 2, 2013, Pages 121-129

  Attallah, Abdelfattah M ^a   El Far, Mohamed ^b   Omran, Mohamed M ^c   Farid, Khaled ^d   Albannan, Mohamed S ^a   El Dosoky, Ibrahim ^d  

^a Biotechnology Research Center of New Damietta   (Egypt)

^b Mansoura University   (Egypt)

^c Helwan University   (Egypt)

^d MANSOURA UNIVERSITY   (Egypt)

Author keywords

APRI; Biotechnology Research Center score; Blood markers; Hepatitis C virus; Liver biopsy

Indexed keywords

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALANINE AMINOTRANSFERASE RATIO; ARTICLE; ASPARTATE TO PLATELET RATIO INDEX; BIOTECHNOLOGY RESEARCH CENTER SCORE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; FIBRO ALPHA SCORE; HEPATITIS C; HUMAN; HUMAN TISSUE; KINGS SCORE; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; STATISTICAL ANALYSIS; VALIDATION STUDY;

ADULT; ANALYSIS OF VARIANCE; AREA UNDER CURVE; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LINEAR MODELS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; ROC CURVE;

HEPATITIS C VIRUS;

EID: 84875614693     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.21572     Document Type: Article

References (43)

1. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-562.
2. WHO. Hepatitis C: Global prevalence. Wkly Epidemiol Rec 1997;72:341-344.
3. Frank C, Mohamed MK, Strickland GT, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000;355:887-891.
4. Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL. Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis 2000;182:698-707
5. Yeshua H, Oren R. Non invasive assessment of liver fibrosis. Ann Transplant 2008;13:5-11.
6. Marcellin P, Asselah T, Boyer N. Fibrosis and disease progression in hepatitis C. Hepatology 2002;36:S47-S56.
7. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002;347:975-982.
8. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001;345:41-52.
9. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: Results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000;32:477-481.
10. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001;344:495-500.
11. Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38:1449-1457.
12. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002;97:2614-2618.
13. Friedman SL. Liver fibrosis - from bench to bedside. J Hepatol 2003;38:S38-S53.
14. Sebastiani G, Alberti A. Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol 2006;12:3682-3694.
15. Sebastiani G. Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms. World J Gastroenterol 2009;15:2190-2203.
16. Denzer UW, Lüth S. Non-invasive diagnosis and monitoring of liver fibrosis and cirrhosis. Best Pract Res Clin Gastroenterol 2009;23:453-460.
17. Sheth SG, Flamm SL, Gordon FD, Chopra S. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1998;93:44-48.
18. Williams AL, Hoofnagle JH. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterol 1988;95:734-739.
19. Giannini E, Risso D, Botta F, et al. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch Intern Med 2003;163:218-224.
20. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-526.
21. Omran MM, Farid K, Emran TM, Attallah AA. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients. Arab J Gastroenterol 2011;12:74-79.
22. Cross TJ, Rizzi P, Berry PA, Bruce M, Portmann B, Harrison PM. King's score: An accurate marker of cirrhosis in chronic hepatitis C. Eur J Gastroenterol Hepatol 2009;21:730-738.
23. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997;349:825-832.
24. Manning DS, Afdhal NH. Diagnosis and quantitation of fibrosis. Gastroenterology 2008;134:1670-1681.
25. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-843.
26. Forns X, Ampurdanès S, Llovet JM, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002;36:986-992.
27. Forns X, Ampurdanès S, Sanchez-Tapias JM, et al. Long-term follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center. J Hepatol 2001;35:265-271.
28. Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 2001;34:730-739.
29. Ahmad W, Ijaz B, Javed FT, et al. A comparison of four fibrosis indexes in chronic HCV: development of new fibrosis-cirrhosis index (FCI). BMC Gastroenterol 2011;11:44.
30. Vallet-Pichard A, Mallet V, Nalpas B, et al. FIB-4: An inexpensive and ccurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology 2007;46:32-36.
31. Hsieh YY, Tung SY, Lee IL, et al. FibroQ: An easy and useful noninvasive test for predicting liver fibrosis in patients with chronic viral hepatitis. Chang Gung Med J 2009;32:614-622.
32. Stauber RE, Lackner C. Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis C. World J Gastroenterol 2007;13:4287-4294.
33. Myres RP, De Torres M, Imbert-Bismut F, Ratziu V, Charlotte F, Poynard T. MULTIVIRC group: Biochemical markers of fibrosis in patients with chronic hepatitis C: A comparison with prothrombin time, platelet count, and age-platelet index. Dig Dis Sci 2003;48:271-278.
34. Ghany MG, Lok AS, Everhart JE, et al. Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C. Gasteroenterol 2010;138:136-146.
35. Ono E, Shiratori Y, Okudaira T, et al. Platelet count reflects stage of chronic hepatitis C. Hepatol Res 1999;15:192-200.
36. Poynard T, Bedossa P. Age and platelet count: A simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR cooperative study groups. J Viral Hepatitis 1997;4:199-208.
37. Bonacini M, Hadi G, Govindarajan S, Lindsay KL. Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1997;92:1302-1304.
38. Lok AS, Ghany MG, Goodman ZD, et al. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: Results of the HALT-C cohort. Hepatology 2005;42:282-292.
39. Calès P, Oberti F, Michalak S, et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 2005;42:1373-1381.
40. Koda M, Matunaga Y, Kawakami M, Kishimoto Y, Suou T, Murawaki Y. FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology 2007;45:297-306.
41. Pagliaro L, Rinaldi F, Craxì A, et al. Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. A prospective, randomized trial. Dig Dis Sci 1983;28:39-43.
42. Poniachik J, Bernstein DE, Reddy KR, et al. The role of laparoscopy in the diagnosis of cirrhosis. Gastrointest Endosc 1996;43:568-571.
43. Lackner C, Struber G, Liegl B, et al. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology 2005;41:1376-1382.